Distinguished in Heart Attack

Seung W. Rha

Seoul, KR 
Distinguished in Heart Attack
Seoul, KR 
OverviewLocationsClinical Research

Overview

Seung Rha practices in Seoul, Republic of Korea. Mr. Rha is rated as a Distinguished expert by MediFind in the treatment of Heart Attack. His top areas of expertise are Heart Attack, Coronary Artery Spasm, Peripheral Artery Disease, Percutaneous Coronary Intervention (PCI), and Angioplasty.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 52 articles and participated in 2 clinical trials in the study of Heart Attack.

Gender
Male

Locations

Seoul, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized, Prospective , Open Label, Phase 4 Trial of Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention With Drug-eluting Stent
Randomized, Prospective , Open Label, Phase 4 Trial of Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention With Drug-eluting Stent
Enrollment Status: Unknown
Publish Date: February 20, 2020
Intervention Type: Drug
Study Drug: Antiplatelet therapy
Study Phase: Phase 4
Comparison of Complete Lesion Versus Culprit Lesion Revascularization in Acute ST Elevation Myocardial Infarction Patients With Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention
Comparison of Complete Lesion Versus Culprit Lesion Revascularization in Acute ST Elevation Myocardial Infarction Patients With Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention
Enrollment Status: Temporarily_not_available
Publish Date: August 14, 2019
Intervention Type: Procedure
Efficacy of Self-Expanding Nitinol S.M.A.R.T-CONTROL Stent Versus Complete SE Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease : Prospective, Multicenter, Randomized, Controlled Trial (SENS-FP Trial)
Efficacy of Self-Expanding Nitinol S.M.A.R.T-CONTROL Stent Versus Complete SE Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease : Prospective, Multicenter, Randomized, Controlled Trial (SENS-FP Trial)
Enrollment Status: Withdrawn
Publish Date: March 15, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

71 Total Publications

Impact of guideline-directed medical therapy on the cardiac or non-cardiac death in acute myocardial infarction.
Impact of guideline-directed medical therapy on the cardiac or non-cardiac death in acute myocardial infarction.
Journal: The Korean journal of internal medicine
Published: February 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rha's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile